Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak
JAMA Network Open · 15.08.2023 · 6 (8) · e2328950
DOI: 10.1001/jamanetworkopen.2023.28950 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 15.08.2023. Verfasst von Natasha Halasa und 45 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Tract Infections. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Themen: Intensivpflege
Abstract (Originalsprache)
Importance Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections (LRTIs) and infant hospitalization worldwide.
Objective
To evaluate the characteristics and outcomes of RSV-related critical illness in US infants during peak 2022 RSV transmission. Design, Setting, and Participants This cross-sectional study used a public health prospective surveillance registry in 39 pediatric hospitals across 27 US states. Participants were infants admitted for 24 or more hours between October 17 and December 16, 2022, to a unit providing intensive care due to laboratory-confirmed RSV infection. Exposure Respiratory syncytial virus. Main Outcomes and Measures Data were captured on demographics, clinical characteristics, signs and symptoms, laboratory values, severity measures, and clinical outcomes, including receipt of noninvasive respiratory support, invasive mechanical ventilation, vasopressors or extracorporeal membrane oxygenation, and death. Mixed-effects multivariable log-binomial regression models were used to assess associations between intubation status and demographic factors, gestational age, and underlying conditions, including hospital as a random effect to account for between-site heterogeneity.
Results
The first 15 to 20 consecutive eligible infants from each site were included for a target sample size of 600. Among the 600 infants, the median (IQR) age was 2.6 (1.4-6.0) months; 361 (60.2%) were male, 169 (28.9%) were born prematurely, and 487 (81.2%) had no underlying medical conditions. Primary reasons for admission included LRTI (594 infants [99.0%]) and apnea or bradycardia (77 infants [12.8%]). Overall, 143 infants (23.8%) received invasive mechanical ventilation (median [IQR], 6.0 [4.0-10.0] days). The highest level of respiratory support for nonintubated infants was high-flow nasal cannula (243 infants [40.5%]), followed by bilevel positive airway pressure (150 infants [25.0%]) and continuous positive airway pressure (52 infants [8.7%]). Infants younger than 3 months, those born prematurely (gestational age <37 weeks), or those publicly insured were at higher risk for intubation. Four infants (0.7%) received extracorporeal membrane oxygenation, and 2 died. The median (IQR) length of hospitalization for survivors was 5 (4-10) days. Conclusions and Relevance In this cross-sectional study, most US infants who required intensive care for RSV LRTIs were young, healthy, and born at term. These findings highlight the need for RSV preventive interventions targeting all infants to reduce the burden of severe RSV illness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
- Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
- Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
- Divisions of Pediatric Infectious Diseases and Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.
- Division of Pediatric Critical Care Medicine, Rainbow Babies and Children's Hospital, Cleveland, Ohio.
- Department of Pediatrics, Connecticut Children's Medical Center, Hartford.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Halasa, N., Zambrano, L. D., Amarin, J. Z., Stewart, L. S., Newhams, M. M., Levy, E. R., Shein, S. L., Carroll, C. L., Fitzgerald, J. C., Michaels, M. G., Bline, K., Cullimore, M. L., Loftis, L., Montgomery, V. L., Jeyapalan, A. S., Pannaraj, P. S., Schwarz, A. J., Cvijanovich, N. Z., Zinter, M. S., …, & RSV-PIC Investigators (2023). Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak. JAMA Network Open, 6(8), e2328950. https://doi.org/10.1001/jamanetworkopen.2023.28950
Vancouver
Halasa N, Zambrano LD, Amarin JZ, Stewart LS, Newhams MM, Levy ER, et al. Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak. JAMA Network Open. 2023;6(8):e2328950. doi:10.1001/jamanetworkopen.2023.28950
BibTeX
@article{Halasa2023,
author = {Halasa, Natasha and Zambrano, Laura D and Amarin, Justin Z and Stewart, Laura S and Newhams, Margaret M and Levy, Emily R and Shein, Steven L and Carroll, Christopher L and Fitzgerald, Julie C and Michaels, Marian G and Bline, Katherine and Cullimore, Melissa L and Loftis, Laura and Montgomery, Vicki L and Jeyapalan, Asumthia S and Pannaraj, Pia S and Schwarz, Adam J and Cvijanovich, Natalie Z and Zinter, Matt S and Maddux, Aline B and Bembea, Melania M and Irby, Katherine and Zerr, Danielle M and Kuebler, Joseph D and Babbitt, Christopher J and Gaspers, Mary Glas and Nofziger, Ryan A and Kong, Michele and Coates, Bria M and Schuster, Jennifer E and Gertz, Shira J and Mack, Elizabeth H and White, Benjamin R and Harvey, Helen and Hobbs, Charlotte V and Dapul, Heda and Butler, Andrew D and Bradford, Tamara T and Rowan, Courtney M and Wellnitz, Kari and Staat, Mary Allen and Aguiar, Cassyanne L and Hymes, Saul R and Randolph, Adrienne G and Campbell, Angela P and RSV-PIC Investigators, RSV-PIC Investigators},
title = {Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {8},
pages = {e2328950},
doi = {10.1001/jamanetworkopen.2023.28950}
}
EUVIMED